Skip to Main Content

Filter:

The Compass

1 Results

Perspectives and controversies
Public Health Crises and the Human Subjects of Biomedical Research: A Focus on COVID-19
Mayo Clinic Proceedings
Vol. 95Issue 6p1130–1131Published online: April 20, 2020
- Taimur Sher
- R. Scott Wright
Cited in Scopus: 0
The widespread social and economic disruption caused by the novel coronavirus disease 2019 (COVID-19) is clearly apparent and has affected all walks of life. The biomedical research enterprise is no exception. According to the 2015-2016 Global Participation in Clinical Trials Report published by the US Food and Drug Administration (FDA),¹ there were 40,385 clinical trial participants in the United States during that time period. Given exponential advances in biotechnology, it is expected that this number has grown considerably over the past 5 years.